Konstantinov Konstantin
- SEC CIK
- 0001774649
No open-market purchases or sales filed in the past year.
Current role at each company
- RGEN Repligen CorpDirectoras of May 18, 2026
- CDAK Codiak BioSciences, Inc.Chief Technology Officeras of Mar 30, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Konstantinov Konstantin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CDAK Codiak BioSciences, Inc.
Chief Technology Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2023 (view filing)5:13 PM ET | Mar 28 | 2 days | Konstantinov KonstantinChief Technology Officer | SSale | −9.36K | $0.2001 | −$1.87K | −100.0%0 after | 2 lots |
| Feb 21, 2023 (view filing) | Aug 17, 2022-Feb 17, 2023 | 188 daysLate | Konstantinov KonstantinChief Technology Officer | SSale | −2.70K | $1.38 | −$3.71K | −26.6%7.43K after | 2 lots |
| Jan 23, 2023 (view filing) | Jan 20 | 3 days | Konstantinov KonstantinChief Technology Officer | SSale | −1.07K | $0.58 | −$620.02 | −38.2%1.73K after | |
| Sep 28, 2021 (view filing) | Jun 8 | 112 daysLate | Konstantinov KonstantinChief Technology Officer | SSale | −7.28K | $25.60 | −$186.3K | −100.0%0 after | 2 lots |